Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Merkel Cell × Saline Solution × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Pain, Postoperative 16 Lung Neoplasms 12 Neoplasms 11 Brain Neoplasms 10 Depression 6 Carcinoma, Hepatocellular 6 Thyroid Neoplasms 5 Prostatic Neoplasms 5 Colonic Neoplasms 5 Stomach Neoplasms 4 Pain 4 Ovarian Neoplasms 4 Leiomyoma 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Anxiety Disorders 4 Supratentorial Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Myofibroma 3 Multiple Myeloma 3 Lymphoma 3 Hemorrhage 3 Fatigue 3 Emergence Delirium 3 Delirium 3 Chronic Pain 3 Carcinoma, Non-Small-Cell Lung 3 Agnosia 3

Interventions

pembrolizumab 12 avelumab 8 Radiotherapy 8 Nivolumab 7 cemiplimab 4 Radiation 4 Ipilimumab 4 poly ICLC 3 atezolizumab 3 Cyclophosphamide 3 talimogene laherparepvec 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 aldesleukin 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Interferon-beta 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2 Biopsy 2 veliparib 1 vatalanib 1 tremelimumab 1 tocilizumab 1 temsirolimus 1 sargramostim 1 sapanisertib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03271372 2025-09-17

ADAM

University of Washington

Phase 3 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡